PaxMedica (PXMD) Competitors

Ampio Pharmaceuticals (NYSE:AMPE) and PaxMedica (NASDAQ:PXMD) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability, community ranking and risk.

Does the media prefer AMPE or PXMD?

In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for PaxMedica. Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled PaxMedica'saverage media sentiment score.

Company	Overall Sentiment
Ampio Pharmaceuticals	Neutral
PaxMedica	Neutral

Does the MarketBeat Community prefer AMPE or PXMD?

PaxMedica received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave PaxMedica an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Ampio Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 78 100.00%
PaxMedica	Outperform Votes 1 100.00%	Underperform Votes No Votes

Do institutionals & insiders have more ownership in AMPE or PXMD?

5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. Comparatively, 4.9% of PaxMedica shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by insiders. Comparatively, 1.0% of PaxMedica shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has stronger valuation & earnings, AMPE or PXMD?

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ampio Pharmaceuticals	N/A	N/A	-$8.63M	-$11.01	0.00
PaxMedica	N/A	N/A	-$18.29M	N/A	N/A

Which has more risk & volatility, AMPE or PXMD?

Ampio Pharmaceuticals has a beta of 3.9, indicating that its stock price is 290% more volatile than the S&P 500. Comparatively, PaxMedica has a beta of -1.32, indicating that its stock price is 232% less volatile than the S&P 500.

Is AMPE or PXMD more profitable?

Ampio Pharmaceuticals' return on equity of 0.00% beat PaxMedica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ampio Pharmaceuticals	N/A	N/A	N/A
PaxMedica	N/A	-3,167.89%	-560.35%

Summary

Ampio Pharmaceuticals beats PaxMedica on 7 of the 9 factors compared between the two stocks.